- Transplantation – prediction of infectious risk
- Vaccine development (IFNγ)
- Th1/Th2, T-cell regulation analysis
- Monocyte and Dendritic cell analysis
- Autoimmune disease
- Cancer – tumor antigens
- Allergy
- Viral infection monitoring and treatment
Advantages of ELISPOT
- Sensitive assay
- Functional assay
- Adaptable
The enzyme-linked immunospot assay (ELISpot) resembles the enzyme-linked immunosorbent assay (ELISA). In both techniques pairs of antibodies are used: primary antibodies (catching antibodies) and secondary antibodies (detecting antibodies). Beside this, however, there are more differences than similarities. Thanks to these differences, ELISpot overcomes certain limitations of ELISA. Moreover, combining both techniques in one experiment supplies additional information, e.g. it is possible to calculate the mean production of a cytokine by single stimulated cell (e.g. pg per cell).
ELISA gives you information about how much cytokine is produced and secreted at a given point of time, but no information about how many cells are secretors of the cytokine.
In ELISPOT there is possibility of detecting parallel secretion of 2 proteins by the same cell
Cellular Technology Limited – Technical Resource
Got something to say about this post? Leave a comment…your comments are valuable for improving the posts.